BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 16424916)

  • 1. Antibody targeted drugs as cancer therapeutics.
    Schrama D; Reisfeld RA; Becker JC
    Nat Rev Drug Discov; 2006 Feb; 5(2):147-59. PubMed ID: 16424916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.
    Ronca R; Sozzani S; Presta M; Alessi P
    Immunobiology; 2009; 214(9-10):800-10. PubMed ID: 19625102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
    Lorberboum-Galski H
    Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody drug conjugates - Trojan horses in the war on cancer.
    Iyer U; Kadambi VJ
    J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria toxin conjugate therapy of cancer.
    Frankel AE; Powell BL; Lilly MB
    Cancer Chemother Biol Response Modif; 2002; 20():301-13. PubMed ID: 12703211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-based therapeutics in oncology.
    Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody conjugate therapeutics: challenges and potential.
    Teicher BA; Chari RV
    Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeting of antitumor drugs with monoclonal antibodies].
    Monneret C; Florent JC
    Bull Cancer; 2000 Nov; 87(11):829-38. PubMed ID: 11125291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-drug conjugates as targeted cancer therapeutics.
    Sun Y; Yu F; Sun BW
    Yao Xue Xue Bao; 2009 Sep; 44(9):943-52. PubMed ID: 20055167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody conjugates and therapeutic strategies.
    McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
    Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-targeted therapeutics in anticancer therapy.
    Allen TM
    Nat Rev Cancer; 2002 Oct; 2(10):750-63. PubMed ID: 12360278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric fusion proteins--Pseudomonas exotoxin-based.
    Kreitman RJ
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1282-93. PubMed ID: 11717817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
    Potala S; Sahoo SK; Verma RS
    Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of humanized antibodies as cancer therapeutics.
    Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
    Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel radiolabeled antibody conjugates.
    Goldenberg DM; Sharkey RM
    Oncogene; 2007 May; 26(25):3734-44. PubMed ID: 17530026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted toxins.
    Frankel AE; Kreitman RJ; Sausville EA
    Clin Cancer Res; 2000 Feb; 6(2):326-34. PubMed ID: 10690507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
    Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ
    Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.